EDGAR Filing Documents for 0001144204-17-031582

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001144204-17-031582

Filing Date

2017-06-07

Accepted

2017-06-07 17:43:24

Documents

Period of Report

2016-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	v467961_form4.html	4
1	FORM 4	v467961_form4.xml	4	16117
	Complete submission text file	0001144204-17-031582.txt		17868

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014

Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500

Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-55668 | Film No.: 17898182
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014

Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507

MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
SIC: 2834 Pharmaceutical Preparations